Search
Revelation Biosciences Inc
REVBAdd to Watchlist
0.959USD
-0.021-2.14%
Market hours 09/23, 09:32（ET）
3.75MMarket Cap
LossP/E TTM
Revelation Biosciences Inc (REVB) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Revelation Biosciences Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.750USD+1807.78%
REVB Analyst Recommendation Trends
In the current month, REVB has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. REVB average Analyst price target in the last month is 17.750.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
Financial Forecasting
Based on analysts' estimates, REVB EPS is projected to reach -0.880 in FY2026Q3, following reported EPS of -0.868 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-3.66
-1.15
-0.83
-0.88
-0.85
Actual
-1.64
-2.71
-0.87
--
--
Surprise
+55.27%
-135.59%
-4.56%
--
--
FAQs
What is Revelation Biosciences Inc's price target?
Analysts forecast that Revelation Biosciences Inc's price target is USD 21.25, with the highest forecast at USD 22.50 and the lowest forecast at USD 20.00.
How have Revelation Biosciences IncREVB's recent earnings per share performed?
The market expectation was USD -0.87, while Revelation Biosciences IncREVB's earnings per share (EPS) for the previous quarter was USD -2.71. EPS for the next quarter is expected at USD -0.88.
What is the analyst rating for Revelation Biosciences Inc?
Based on the ratings of Revelation Biosciences Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.